FI61900C - Foerfarande foer framstaellning av terapeutiskt anvaendbara 7-aryloxialkylaminoalkyl)teofylliner - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara 7-aryloxialkylaminoalkyl)teofylliner Download PDF

Info

Publication number
FI61900C
FI61900C FI771187A FI771187A FI61900C FI 61900 C FI61900 C FI 61900C FI 771187 A FI771187 A FI 771187A FI 771187 A FI771187 A FI 771187A FI 61900 C FI61900 C FI 61900C
Authority
FI
Finland
Prior art keywords
group
compound
formula
iti
hydrochloride
Prior art date
Application number
FI771187A
Other languages
English (en)
Finnish (fi)
Other versions
FI771187A (US07368563-20080506-C00056.png
FI61900B (fi
Inventor
Heribert Offermanns
Karl Heinz Klingler
Klaus Thiemer
Fritz Stroman
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of FI771187A publication Critical patent/FI771187A/fi
Application granted granted Critical
Publication of FI61900B publication Critical patent/FI61900B/fi
Publication of FI61900C publication Critical patent/FI61900C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI771187A 1976-04-15 1977-04-14 Foerfarande foer framstaellning av terapeutiskt anvaendbara 7-aryloxialkylaminoalkyl)teofylliner FI61900C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1554776 1976-04-15
GB15547/76A GB1527543A (en) 1976-04-15 1976-04-15 Basically substituted xanthine derivatives

Publications (3)

Publication Number Publication Date
FI771187A FI771187A (US07368563-20080506-C00056.png) 1977-10-16
FI61900B FI61900B (fi) 1982-06-30
FI61900C true FI61900C (fi) 1982-10-11

Family

ID=10061083

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771187A FI61900C (fi) 1976-04-15 1977-04-14 Foerfarande foer framstaellning av terapeutiskt anvaendbara 7-aryloxialkylaminoalkyl)teofylliner

Country Status (28)

Country Link
US (1) US4144340A (US07368563-20080506-C00056.png)
JP (1) JPS52128396A (US07368563-20080506-C00056.png)
AR (1) AR217426A1 (US07368563-20080506-C00056.png)
AT (1) AT350070B (US07368563-20080506-C00056.png)
AU (1) AU511983B2 (US07368563-20080506-C00056.png)
BE (1) BE853571A (US07368563-20080506-C00056.png)
CA (1) CA1078379A (US07368563-20080506-C00056.png)
CH (1) CH631454A5 (US07368563-20080506-C00056.png)
CS (1) CS196357B2 (US07368563-20080506-C00056.png)
DE (1) DE2716210A1 (US07368563-20080506-C00056.png)
DK (1) DK141051B (US07368563-20080506-C00056.png)
ES (2) ES457783A1 (US07368563-20080506-C00056.png)
FI (1) FI61900C (US07368563-20080506-C00056.png)
FR (1) FR2361395A1 (US07368563-20080506-C00056.png)
GB (1) GB1527543A (US07368563-20080506-C00056.png)
GR (1) GR63643B (US07368563-20080506-C00056.png)
IN (1) IN145872B (US07368563-20080506-C00056.png)
IT (1) IT1143568B (US07368563-20080506-C00056.png)
MX (1) MX5064E (US07368563-20080506-C00056.png)
NL (1) NL7704087A (US07368563-20080506-C00056.png)
NO (1) NO148291C (US07368563-20080506-C00056.png)
NZ (1) NZ183859A (US07368563-20080506-C00056.png)
PL (1) PL106083B1 (US07368563-20080506-C00056.png)
PT (1) PT66442B (US07368563-20080506-C00056.png)
RO (1) RO72835A (US07368563-20080506-C00056.png)
SE (1) SE431335B (US07368563-20080506-C00056.png)
SU (1) SU668604A3 (US07368563-20080506-C00056.png)
ZA (1) ZA772294B (US07368563-20080506-C00056.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935062A1 (de) * 1978-09-06 1980-03-20 Degussa Substituierte aminoalkylguanidine, deren herstellung und arzneimittel
EP0022321A1 (en) * 1979-07-10 1981-01-14 Beecham Group Plc Benzene derivatives, their preparation and use in pharmaceutical compositions
DE2929596A1 (de) * 1979-07-21 1981-02-05 Hoechst Ag Verfahren zur herstellung von oxoalkyl-xanthinen
CH655658B (US07368563-20080506-C00056.png) * 1980-09-18 1986-05-15
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4406903A (en) * 1981-01-21 1983-09-27 John Wyeth And Brother Limited Xanthine derivatives useful as antidepressives
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT308139B (de) * 1970-07-27 1973-06-25 Degussa Verfahren zur Herstellung von neuen basisch substituierten Alkyltheophyllinen, ihren Isomeren und Säureadditionssalzen
AT311995B (de) * 1971-09-06 1973-12-10 Degussa Verfahren zur Herstellung von neuen basisch substituierten Alkyltheophyllinen
AT313916B (de) * 1971-10-28 1974-03-11 Degussa Verfahren zur Herstellung von neuen basisch substituierten Theophyllinen und deren Säureadditionssalzen
DE2308826C3 (de) * 1973-02-22 1980-03-27 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Phenoxyalkancarbonsäureester von Oxyalkyltheophyllinen, Verfahren zu ihrer Herstellung und Arzneimittel

Also Published As

Publication number Publication date
ES457783A1 (es) 1978-03-01
JPS52128396A (en) 1977-10-27
NO148291C (no) 1983-09-14
CA1078379A (en) 1980-05-27
FI771187A (US07368563-20080506-C00056.png) 1977-10-16
RO72835B (ro) 1983-07-30
DK166677A (US07368563-20080506-C00056.png) 1977-10-16
AU511983B2 (en) 1980-09-18
PT66442A (pt) 1977-05-01
SU668604A3 (ru) 1979-06-15
US4144340A (en) 1979-03-13
FR2361395B1 (US07368563-20080506-C00056.png) 1981-02-13
GB1527543A (en) 1978-10-04
DE2716210A1 (de) 1977-11-03
SE7704319L (sv) 1977-11-28
SE431335B (sv) 1984-01-30
NZ183859A (en) 1979-03-28
AU2425677A (en) 1978-10-19
GR63643B (en) 1979-11-28
FI61900B (fi) 1982-06-30
RO72835A (ro) 1983-08-03
CH631454A5 (de) 1982-08-13
AT350070B (de) 1979-05-10
ZA772294B (en) 1978-03-29
BE853571A (nl) 1977-10-14
FR2361395A1 (fr) 1978-03-10
ATA262677A (de) 1978-10-15
DK141051C (US07368563-20080506-C00056.png) 1980-06-16
MX5064E (es) 1983-03-09
NO148291B (no) 1983-06-06
DK141051B (da) 1979-12-31
CS196357B2 (en) 1980-03-31
IN145872B (US07368563-20080506-C00056.png) 1979-01-06
ES457784A1 (es) 1978-03-01
PL106083B1 (pl) 1979-11-30
IT1143568B (it) 1986-10-22
AR217426A1 (es) 1980-03-31
PT66442B (pt) 1978-09-22
NL7704087A (nl) 1977-10-18
NO771301L (no) 1977-10-18

Similar Documents

Publication Publication Date Title
Chaudhary et al. Combretastatin A-4 analogs as anticancer agents
CN110028475B (zh) 基于苯并吡喃结构的新型cdk9抑制剂、其制备方法及应用
JP3176935B2 (ja) ドーパミンリセプタサプタイプ特異性リガンドとしてのn―アミノアルキルジベンゾフランカルボキサミド
AU608580B2 (en) 1,4-disubstituted piperazine compounds, their production and use
FI61900C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 7-aryloxialkylaminoalkyl)teofylliner
JP2022119990A (ja) アポトーシス誘発剤
KR0165131B1 (ko) 1,4-벤조티아제핀 유도체
FI112649B (fi) Menetelmä terapeuttisesti käyttökelpoisten diamiiniyhdisteiden valmistamiseksi
Du et al. Synthesis and biological evaluation of bivalent β-carbolines as potential anticancer agents
JPS6072891A (ja) ピリミド〔4,5−g〕キノリンおよびその製造中間体
RU2091379C1 (ru) Дифенилметилпиперазиновые производные или их фармацевтически приемлемая соль
HU184719B (en) Process for the preparation of heterocyclic oxy-propanolamine derivatives
EP2139889B1 (en) Amino-naphthyridine derivatives
HRP930508A2 (en) Difenilpropilamina process for the preparation of the novel enylpropylamine derivatives
US4450115A (en) Amino-alcohol derivatives
US8450318B2 (en) Method to treat infections using anti-infective agents
FI58325B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla sulfamider
RU2086548C1 (ru) Дигидропиридиновые производные или их фармацевтически приемлемые соли и фармацевтическая композиция на их основе
CZ34296A3 (en) Derivative of bis-naphthalimide, process of its preparation and pharmaceutical composition containing thereof
US4598084A (en) Optically active derivatives of N-arylated oxazolidine-2-one, the process for preparing same and their application in therapeutics
US4883798A (en) Pharmaceutical compositions
US4526989A (en) 1,4-Bis (substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
US20100113505A1 (en) Amino-naphthyridine derivatives
RU2060249C1 (ru) Полициклические биоцидные соединения и фармацевтическая композиция на их основе
JPH0345042B2 (US07368563-20080506-C00056.png)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: DEGUSSA AKTIENGESELLSCHAFT